SCHEMBL10135252

SCHEMBL10135252

OCCCOc1nc2ccccc2c2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.70
TOP2A P11388 1/20 0.47
POLB P06746 2/20 0.46
RAD52 P43351 2/20 0.46
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
CYP1B1 Q16678 2/20 0.43
SYK P43405 1/20 0.43
PADI4 Q9UM07 1/20 0.42
RAB9A P51151 3/20 0.41
TSHR P16473 2/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702757 0.84 PARP1 (0.67) PARP1TOP2ARAD52CSNK2A2CSNK2B
SCHEMBL4969520 0.83 PARP1 (1.00) PARP1CSNK2A2CSNK2BCSNK2A1RAB9A
SCHEMBL7283175 0.83 MAPT (0.51) PARP1TOP2ARAB9ATSHRNPC1
SCHEMBL14046155 0.81 GAA (0.54) PARP1TOP2APOLBKDM4EALDH1A1
SCHEMBL10135251 0.80 PARP1 (0.62) PARP1POLBRAD52CSNK2A2CSNK2B
SCHEMBL16695661 0.80 PARP1 (0.49) PARP1TOP2APOLBRAD52CSNK2A2
SCHEMBL12460975 0.75 PARP1 (0.48) PARP1TOP2ACYP1B1LTB4R
SCHEMBL1366924 0.75 HDAC1 (0.59) PARP1
SCHEMBL10168923 0.75 PARP1 (0.56) PARP1CSNK2A2CSNK2BCSNK2A1CYP1B1
SCHEMBL14027310 0.72 GPR3 (0.44) PARP1TOP2APOLBTSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208792-A1 PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-08-16 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208792-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 PARP1 690/4885TOP2A 2859/4885POLB 894/4885
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 PARP1 690/4885TOP2A 2859/4885POLB 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.